~~<i id='CF78E8886B'><strike id='CF78E8886B'><tt id='CF78E8886B'><pre id='CF78E8886B'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：hotspot 2025-09-29 09:06:47 Page View：3

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Adele warns fans about throwing things at performers onstage
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

explore

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

EU moves toward latest gene techniques in food production to counter climate change, shortages

FILE-EuropeanCommissionerforEuropeanGreenDealFransTimmermansspeaksduringamediaconferenceonthreatsofc

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

MembersofthemediagatheroutsidetheShevchenskivskyicourtduringanewsconferencebyUkraine'sMinisterofInte